Nurix Therapeutics, Inc. (NRIX)

20.91 -0.56 (-2.61%) USD  |  NASDAQ  |  Dec 09, 11:59
More

Nurix Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NRIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Pfizer Inc. Upgrade
EyePoint Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade